HK1204917A1 - 淫羊藿苷元在製備治療或預防血小板減少症藥物中的用途 - Google Patents

淫羊藿苷元在製備治療或預防血小板減少症藥物中的用途

Info

Publication number
HK1204917A1
HK1204917A1 HK15105403.3A HK15105403A HK1204917A1 HK 1204917 A1 HK1204917 A1 HK 1204917A1 HK 15105403 A HK15105403 A HK 15105403A HK 1204917 A1 HK1204917 A1 HK 1204917A1
Authority
HK
Hong Kong
Prior art keywords
arctigenin
sublingually
buccal formulation
buccal
formulation
Prior art date
Application number
HK15105403.3A
Other languages
English (en)
Inventor
濤李光豔孫成宏 趙志全李
Original Assignee
Lunan Pharm Group Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lunan Pharm Group Corp filed Critical Lunan Pharm Group Corp
Publication of HK1204917A1 publication Critical patent/HK1204917A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15105403.3A 2013-10-21 2015-06-08 淫羊藿苷元在製備治療或預防血小板減少症藥物中的用途 HK1204917A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310493718.4A CN104546823B (zh) 2013-10-21 2013-10-21 淫羊藿苷元在制备治疗或预防血小板减少症药物中的用途

Publications (1)

Publication Number Publication Date
HK1204917A1 true HK1204917A1 (zh) 2015-12-11

Family

ID=53064606

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105403.3A HK1204917A1 (zh) 2013-10-21 2015-06-08 淫羊藿苷元在製備治療或預防血小板減少症藥物中的用途

Country Status (2)

Country Link
CN (1) CN104546823B (zh)
HK (1) HK1204917A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104688722B (zh) * 2013-12-04 2019-10-01 鲁南制药集团股份有限公司 淫羊藿苷元在制备预防或治疗骨髓抑制药物中的用途
CN105476957B (zh) * 2014-12-18 2021-04-20 北京珅奥基医药科技有限公司 一种阿可拉定注射剂及其制备方法和用途
CN113368098B (zh) * 2020-03-10 2024-03-29 鲁南制药集团股份有限公司 淫羊藿苷元在制备血友病防治药物中的用途
EP4119139A4 (en) * 2020-03-10 2024-03-20 Lunan Pharmaceutical Group Corporation MEDICAL USE OF ANYHDROICARITIN
CN113368099B (zh) * 2020-03-10 2024-03-26 鲁南制药集团股份有限公司 淫羊藿苷元在制备血小板功能异常相关疾病防治药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1194701C (zh) * 2003-06-08 2005-03-30 浙江大学 淫羊藿素或去甲基淫羊藿素在制备雌激素受体调节剂中的应用
CN101812100A (zh) * 2010-04-08 2010-08-25 苏州宝泽堂医药科技有限公司 一种制备淫羊藿苷的方法
CN102440986B (zh) * 2010-10-08 2014-12-03 鲁南制药集团股份有限公司 牛蒡子苷元在制备防治辐射或化学品引起的骨髓抑制的药物中的用途

Also Published As

Publication number Publication date
CN104546823A (zh) 2015-04-29
CN104546823B (zh) 2019-08-30

Similar Documents

Publication Publication Date Title
IL274024A (en) Oral preparations
IL279395A (en) A vaccine
HRP20190173T1 (hr) Oralne formulacije deferasiroksa
EP3065716C0 (en) FORMULATIONS
ZA201507685B (en) Sublingual and buccal film compositions
GB201304662D0 (en) Compositions
SG11201602331QA (en) Compositions and methods utilizing lysophosphatidylcholine scaffolds
GB201313615D0 (en) Compositions
PT3091991T (pt) Composições imunomodulatórias
GB201319792D0 (en) Formulations
HK1224228A1 (zh) 新型製劑
HK1214951A1 (zh) 眼用製劑
GB201320432D0 (en) Novel formulation
HK1204917A1 (zh) 淫羊藿苷元在製備治療或預防血小板減少症藥物中的用途
DOS2012000192S (es) Confiteria
GB201322948D0 (en) Improved formulation
GB201316463D0 (en) Novel compositions
GB2517232B (en) Formulation
GB201320962D0 (en) Compositions
EP3068376A4 (en) Ondansetron sublingual spray formulation
GB201317718D0 (en) Novel formulation
PT3041488T (pt) Composições de mel
GB201320959D0 (en) Compositions
DOS2012000191S (es) Confiteria
HK1209981A1 (zh) 配方